## UNH: UnitedHealth Group Incorporated - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 1.35 indicates fundamental undervaluation. Quality metrics strong (ROE 18%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($318.41)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Gabelli Funds LLC Lowers Stock Position in UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251209T094520 | Somewhat-Bullish | Relevance: 99%
-  Gabelli Funds LLC reduced its stake in UnitedHealth Group (NYSE:UNH) by 24.7% in the second quarter, selling 9,570 shares and ending with 29,170 shares valued at $9.1 million. Despite this reduction, other institutional investors either increased their holdings or initiated new positions. The company recently reported strong quarterly earnings, beating EPS estimates, and declared a quarterly dividend of $2.21 per share.

**2. Investment Management Corp of Ontario Has $9.61 Million Holdings in UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251209T140845 | Bullish | Relevance: 98%
-  Investment Management Corp of Ontario increased its stake in UnitedHealth Group Incorporated to $9.61 million, amounting to 30,813 shares, representing an 18.4% rise in the second quarter. Other hedge funds like Brighton Jones LLC and Revolve Wealth Partners LLC also adjusted their positions, and institutional investors collectively own 87.86% of the company. Analysts generally rate UNH as a "Hold" with a consensus price target of $385.54, though many have "Buy" ratings and higher price targets.

**3. Axa S.A. Sells 155,294 Shares of UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251209T083459 | Neutral | Relevance: 98%
-  Axa S.A. has reduced its stake in UnitedHealth Group by 34.6%, selling 155,294 shares and now holding 293,176 shares valued at $91.46 million. Despite this, institutional ownership remains high at 87.86%, with other major investors like Norges Bank and Dodge & Cox significantly increasing their positions. UnitedHealth Group reported strong Q3 earnings, beating EPS estimates, and announced a quarterly dividend of $2.21, reflecting a 2.7% yield.

**4. Daiwa Securities Group Inc. Increases Stock Position in UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251209T103146 | Somewhat-Bullish | Relevance: 98%
-  Daiwa Securities Group Inc. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% in Q2 2025, bringing its total holdings to 223,981 shares valued at $69.88 million. The article details other institutional investments, UnitedHealth Group's financial performance, recent dividend announcements, and current analyst ratings, with the stock holding an average "Hold" rating and a consensus target price of $385.54.

**5. UnitedHealth Group Incorporated $UNH Shares Purchased by London & Capital Asset Management Ltd**
- Source: MarketBeat | 20251209T131807 | Somewhat-Bullish | Relevance: 98%
-  London & Capital Asset Management Ltd significantly increased its stake in UnitedHealth Group Incorporated (NYSE:UNH), boosting its shares by 35.6% in the second quarter to own 118,494 shares valued at $36,961,000. Several other institutional investors also adjusted their holdings, with UnitedHealth Group remaining a significant part of many portfolios. Analysts have issued varied ratings, with a consensus "Hold" rating and an average target price of $385.54, while the company recently announced a quarterly dividend of $2.21 per share.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 23 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (-0.3%)
- Blackrock Inc.: 8.2% (-1.4%)
- State Street Corpora: 4.9% (-1.8%)
- JPMORGAN CHASE & CO: 4.1% (+85.6%)
- Geode Capital Manage: 2.4% (+2.2%)

### Key Risks

1. Long-term trend broken: trading 6.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.35 suggests fair value with growth premium. Forward P/E 19.0x stretched relative to 9% growth. Balance sheet: $5.1B free cash flow. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $305.0B |
| Beta | 0.43 |
| 52W Range | $234.60 - $606.36 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.35 |
| Forward P/E | 19.0 |
| Current P/E | 20.6 |
| YoY Growth | 8.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -1.0% to 1.6% (+2.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.5pp (needs >4.0% for momentum thesis). MRS_5 at 2.6% confirms short-term momentum alignment. AM_20 at 3.8% shows strong absolute momentum above own 20MA. Outperforming sector by 3.9pp, stock-specific strength. Below SMA200 (0.94x), long-term trend not supportive. MACD histogram positive (1.73), confirming momentum. RSI neutral at 55.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.55% (CS: 55) | Neutral |
| RSI_14 | 54.9 | Neutral |
| MACD Histogram | 1.73 | Bullish |
| vs SMA20 | 1.036x | Above |
| vs SMA50 | 0.988x | Below |
| vs SMA200 | 0.938x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $336.73
- **Stop Loss:** $318.41 (5.4% risk)
- **Target:** $373.37 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $25,254.75
- **Portfolio %:** 25.25%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-15 (Est: $2.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.81 | $2.92 | +4.0% |
| 2025Q2 | $4.45 | $4.08 | -8.2% |
| 2025Q1 | $7.29 | $7.20 | -1.3% |
| 2024Q4 | $6.74 | $6.81 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*